A pioneering neonatal study has reported its two-year findings, confirming that a novel approach developed in Australia can improve the lung health of extremely premature infants born with breathing difficulties. The multi-centre OPTIMIST-A trial, in which Murdoch Children’s Research Institute (MCRI) was a key collaborator, enrolled 486 premature babies from 33 neonatal intensive care units around the world during their first hours of life. Researchers compared the use of a novel delivery of surfactant medication, via a flexible thin catheter, to the airways to a ‘sham’ treatment, in tiny premature babies requiring active breathing support in the first hours of
International pioneering neonatal study as seen on The Hippocratic Post.